B-AEA

• Description :

  B-AEA (MM22) is a biotinylated endocannabinoid analog with probe activity. b-AEA is able to accumulate intracellularly in a similar manner to the parent compound AEA. b-AEA does not interact with other components of the endocannabinoid system and therefore does not interfere with their function. b-AEA can be used to visualize the accumulation and intracellular distribution of endocannabinoids[1].

• Product Name Alternative :

  MM22; Biotinylated N-arachidonoylethanolamine

• UNSPSC :

  12352005

• Target :

  Cannabinoid Receptor

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein; Neuronal Signaling

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Others

• Assay Protocol :

  https://www.medchemexpress.com/b-aea.html

• Purity :

  95.89

• Solubility :

  DMSO : 87.5 mg/mL (ultrasonic)

• Smiles :

  O=C(NCCOCCOCCNC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)CCCC[C@@H]1SC[C@]([C@]1([H])N2)([H])NC2=O

• Molecular Formula :

  C36H60N4O5S

• Molecular Weight :

  660.95

• References & Citations :

  [1]Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation

• Shipping Conditions :

  Blue Ice

• Storage Conditions :

  -20°C, 3 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [956605-71-3]